ROBERTO BERMUDEZ: Open Payments
NPI 1780781138 · HOMESTEAD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 47 payments from 11 companies in 2025. Trend: 2023 $585 · 2024 $907 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $437 |
| Amgen Inc. | 17 | $241 |
| Novo Nordisk Inc | 2 | $48 |
| Corcept Therapeutics | 2 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Abbott Laboratories | 2 | $31 |
| Lilly USA, LLC | 1 | $29 |
| ABBVIE INC. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: FARXIGA, OTEZLA, AIRSUPRA, JARDIANCE, KRYSTEXXA, Korlym, ZORYVE, FREESTYLE LIBRE 3.
Industry payments across FL — which companies pay providers there.
